Akinori Mochizuki
Nessuna posizione attualmente
Profilo
Akinori Mochizuki served as Managing Director at Sosei R&D Ltd., Director at Jitsubo Co., Ltd., and Research Scientist-Pharmaceutical Research at Fujirebio, Inc. He also served as Chief Scientific Officer & EVP at Sosei Group Corp.
from 2013 to 2015.
Mochizuki holds a doctorate degree from Toho University and undergraduate and doctorate degrees from Tokyo University of Pharmacy & Life Science.
Precedenti posizioni note di Akinori Mochizuki
Società | Posizione | Fine |
---|---|---|
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | - |
Fujirebio, Inc.
Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Corporate Officer/Principal | - |
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Direttore/Membro del Consiglio | - |
NXERA PHARMA CO., LTD. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Akinori Mochizuki
Toho University | Doctorate Degree |
Tokyo University of Pharmacy & Life Science | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NXERA PHARMA CO., LTD. | Health Technology |
Aziende private | 3 |
---|---|
Fujirebio, Inc.
Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Health Technology |
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Health Technology |
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Akinori Mochizuki